Skip to main content
padlock icon - secure page this page is secure

Free Content Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China

Download Article:
(PDF 93.3 kb)
BACKGROUND: China has nearly one fifth of global multidrug-resistant tuberculosis (MDR-TB) cases, and follows the 24-month World Health Organization (WHO) standardised regimens.

OBJECTIVE: To assess treatment interruption among MDR-TB patients and its association with the provision of directly observed treatment (DOT).

METHODS: We reviewed clinical charts and conducted a questionnaire survey among all confirmed MDR-TB patients who had been treated for at least 6 months from 1 January 2009 to 30 April 2012 in Shandong Province. Treatment interruption was defined as missing a dose for at least 1 day but for <8 consecutive weeks; the subset ‘severe interruption' was defined as missing doses for 2–8 consecutive weeks.

RESULTS: Of 110 patients, 75 (68%) interrupted treatment; 19 (17%) reported severe interruption, with a median duration of 30 days. Of the 110 patients, 26 (24%) received injections from family members and 55 (50%) received DOT, 7 (13%) from village doctors and 48 (87%) from family members. Patients who underwent DOT with a family member had less severe interruptions (OR 0.25, 95%CI 0.05–0.98) than those who were given DOT by a village doctor or who did not undergo DOT.

CONCLUSIONS: Family members may act as treatment supporters for MDR-TB patients to reduce treatment interruptions, but require orientation on their role.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DOT; MDR-TB; community management; family members; treatment interruption

Document Type: Research Article

Affiliations: 1: The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong 2: Nuffield Centre for International Health and Development, University of Leeds China Office, Shenzhen, China 3: Nuffield Centre for International Health and Development, University of Leeds, Leeds, UK 4: Center for TB Control, Shandong Provincial Chest Hospital, Jinan, China 5: Center for Health Management and Policy, Shandong University, Jinan, China 6: National Centre for TB Control and Prevention, China Centre for Disease Control, Beijing, China

Publication date: April 1, 2015

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.

    To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.

    Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more